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SUMMARY. Introduction. Edwards syndrome is the second most common autosomal chromosome anomaly in humans, 
with a prevalence of 1: 6,000–1: 8,000 in live births. The syndrome includes a recognizable pattern of major and minor 
anomalies, and prominent psychomotor and cognitive impairments. It carries an increased risk of neonatal and infant 
mortality. More than 50% of children die in the fi rst week of their life, and less than 10% of them survive until the age 
of one year. The approach to the treatment of such patients has so far caused many controversies among pediatricians. 
Whereas some believe that the use of intensive therapy prolongs survival, others believe that it has no long-term effect 
and due to the severe psychomotor and cognitive impairment its application is not justifi ed. Case report. A female new-
born, born on January 11th, 2014, immediately after birth, was transferred to Neonatal Intensive Care Unit of Department 
of Pediatrics, University Clinical Hospital Mostar, because of hypotonia, pale-grayish color of the skin, defi cient spon-
taneous motor skills and respiratory insuffi ciency. Clinically, the newborn showed phenotypic characteristics typical of 
Edwards syndrome. Immediately upon receipt the patient was intubated and connected to mechanical ventilation. The 
same day diaphragmatic hernia was diagnosed and a corresponding surgery was performed. Cytogenetic fi ndings con-
fi rmed complete trisomy 18. Heart echography showed VSD input type (size 8 mm), ASD II (5 mm), PDA (3 mm). 
Further diagnostic examination showed other congenital malformations with less clinical importance. After stabiliza-
tion, the patient continued post-intensive treatment with cardiac therapy and physiatric treatment. After being discharged, 
the patient was repeatedly hospitalized, among other things due to the development of pulmonary hypertension and its 
complications. The child died in June 2016 of heart failure at the age of two years and six months. Conclusion. The ap-
plication of intensive treatment had a certain impact on our patient’s survival. It has also been shown that intensive care 
is followed by cardiovascular events as major mechanisms of death, as opposed to non-invasive approach where high 
percentage of deaths are associated with central apnea.
Introduction
Edwards syndrome (trisomy 18) is the second most 
common autosomal chromosome anomaly in humans, 
with a prevalence of 1: 6 000 to 1: 8 000 in live births, 
while the overall prevalence is 1: 2 500 to 1: 2 600, due 
to the high incidence of abortions and fetal loss after 
prenatal diagnosis (1). More than 95% of affected chil-
dren have a complete trisomy 18 whereas others are af-
fected because of parental translocation, or mosaicism. 
The syndrome includes recognizable pattern of large 
and small abnormalities, increased risk of neonatal and 
infant mortality and prominent psychomotor and cogni-
tive impairments. The main features are: small face, 
craniofacial dysmorphia, hypoplastic mandible, low-
lying auricles, and characteristic fl exion contractures of 
fi ngers, short sternum and anomalies of the heart, kid-
neys and digestive tract. The clinical picture has more 
than 100 symptoms and signs. Congenital heart defects 
occur in almost all newborns with this syndrome (in 
95–99% of cases), they have a wide range of appear-
ance and are often combined in the same patient. Ac-
cording to the order of frequency these are: VSD, valvu-
lar heart defects, infundibular pulmonary stenosis, 
AVSD, TOF and double output of blood vessels from 
the right ventricle. As in the case of Down’s syndrome, 
the transposition of great vessels or the inversion at any 
level (cardiac or visceral) are not described, which 
seems to be characteristic of these trisomies. The diag-
nosis may be suspected based on impaired ultrasound 
fi ndings or maternal serum screening, and postnatally, 
based on phenotype. In both cases, the diagnosis is con-
fi rmed with cytogenetic analysis (2–4). The main causes 
of mortality are central apnea, heart failure due to car-
diac malformations, respiratory insuffi ciency due to hy-
poventilation, aspiration, upper airway obstruction, and 
combinations of these and other factors (including deci-
sions related to aggressive intensive care). It is impos-
sible to give the prognosis during pregnancy and neona-
tal period (1). More than 50% of children die in the fi rst 
week of life, and less than 10% of them live past the 
fi rst year of life (4).
Case report
A female newborn, the fourth child of six pregnancies 
(previously two miscarriages), was born on January 11th 
2014 at the Department of Gynecology, University 
Clinical Hospital Mostar. The course of pregnancy in 
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pregnancy the mother had vaginal bleeding. Diagnosis 
of placenta praevia totalis was established, and Mg and 
Gynipral administered. Childbirth occurred 11 days af-
ter the due date (due date January 1st 2014), naturally, 
without complications. The newborn had birth weight 
of 2 810 g, length of 52 cm, Apgar score 7/8. Clinically, 
the newborn showed phenotypic characteristics typical 
of Edwards syndrome: microcephaly, wide open fonta-
nelle, wide forehead, small face, hypertelorism, epican-
thic fold, narrow and short opened eyelids, ptosis, small 
nose and mouth, micrognathia, low-lying auricles, short 
neck with excess wrinkled skin, hypoplastic chest, short 
sternum, increased hairiness on the back, changes on 
extremities – clenched fi st with a typical position of fi n-
gers where the second fi nger overlies the third and the 
fi fth overlies the fourth, contracture of fi ngers, hypopla-
sia of radius, dislocation of hips, dorsal fl exion of 
thumb, partial syndactyly of 2nd and 3rd toe. Weakened 
respiratory movements and pale-grayish color of skin 
were noticed after the birth. The clinical condition sta-
bilized after brief ventilation with Ambu mask and 
blood oxygen saturation level rose. The newborn was 
transported with transport incubator to the Neonatology 
and Neonatal Intensive Care Unit, in Pediatrics Clinic.
On receipt the newborn was hypotonic, with pale-
grayish color of skin, defi cient spontaneous motor skills 
and respiratory insuffi ciency – on arrival SpO2 89–91%. 
After primary stabilization, the decrease in hemoglobin 
oxygen saturation was still visible, and the patient was 
intubated and put on mechanical ventilation. ABS of 
capillary blood on admission: pH 7,166; PCO2 86,4 
mmHg; PO2 39,6; SO2 73,3%; CHCO3 30,5 mmol / L; 
BE –1,6 mmol / L. On admission and several times dur-
ing the stay samples for control ABS, laboratory and 
microbiological tests were taken. Radiologic examina-
tion (X-ray babygram) on the fi rst day showed dia-
phragmatic hernia. The surgical procedure of diaphrag-
matic hernia was performed on the same day using gen-
eral endotracheal anesthesia. The planned surgery and 
postoperative period passed without complications. The 
necessary supportive antibiotic and other supportive 
therapy with adequate sedation was provided. On sev-
eral occasions, the newborn received plasma and red 
cell concentrate. After 3 days the patient was extubated 
and removed from mechanical ventilation, which she 
tolerated by taking respiratory therapy and inhalations. 
She was fed on tube. Echography of the heart and great 
vessels (Figure 1, Figure 2) showed the following con-
genital heart defects: inlet VSD type (size 8 mm), ASD 
II (5 mm) and PDA (3 mm), which are stable due to 
taking corresponding cardiotonic (Digoxin salt. 1x1 
drop per os, every day), and diuretic (Lasix 2x1 mg 
orally, every other day). Abdominal ultrasound showed 
hypoplastic right kidney with pyelectasis, left kidney 
bigger with extended channel system intrarenal. Ultra-
sound of the brain and EEG were normal. Bilateral atre-
sia of ear was established by a specialist otorhinolaryn-
gologist otoscopic examination. Cytogenetic fi ndings 
(Figure 3) confi rmed the diagnosis of trisomy 18 on 
January 27th. Using GTG – banding method, the follow-
ing cytogenetic fi ndings were obtained from blood sam-
ple: female karyotype complete trisomy 18 – Sy Ed-
wards (47, XX, + 18). Post-intensive period passed 
without complications. A specialist physiatrist per-
formed examination and the patient was already in-
volved in physiatrist’s treatment during the stay at the 
Clinic. Parents received detailed information regarding 
the diagnosis of Edwards syndrome, and the child was 
released to home treatment on April 7th 2014. Therapy on 
discharge: Lanitop salt. 1x1 drop p.o.; Lasix 2x1 mg 
p.o./every other day; Vitamin D3 salt. 1x4 drops p.o. 
The appointments were made for control examinations 
of children’s cardiologist, nephrologist, neuropediatri-
cian and physiatrist, and the instructions about vaccina-
tion were given to the parents.
Later, the patient was repeatedly hospitalized because 
of gastroenteritis, infection of the respiratory system, 
and complications associated with the development and 
progression of pulmonary hypertension. Over time car-
diac treatment was expanded and the following medica-
tions were added to the previous therapy: Aldactone, 
Enalapril powder and Propanolol. The patient regularly 
Figure 1. ECHO: The view of VSD inlet Figure 2. ECHO: The view of ASD II
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attended controls and was taking prescribed medica-
tions. The last control in our Clinic was in August 2015, 
after which parents and the patient moved abroad. Exi-
tus Letalis took place in June 2016 due to a heart failure 
at the age of two years and six months.
Discussion
In 2008 and 2009, 495 diagnosis of Edwards syn-
drome were established in England and Wales, out of 
which 92% prenatally. Out of this total, 339 pregnan-
cies resulted in abortion, 49 had the following out-
comes: stillbirth / miscarriage / fetal death; there were 
35 live births and 72 with unknown outcomes (5). Most 
recent studies report a median survival of 3–14.5 days, 
a percentage of survival after 24 hours of 60%–75%, 
after 1 week of 40%–60%, after 1 month of 22%–44%, 
after 6 months of 9%–18%, and after 1 year of 5%–10% 
(6–8). The only study known to us for survival of pa-
tients with Edwards syndrome after the second year of 
life states that it is less than 4% (12). Researches linking 
to prevalence and survival of patients with Edwards 
syndrome by gender showed a higher prevalence at 
birth in females compared to males (F: M%, 60,4:39,6). 
However, this difference is not present if ratio is calcu-
lated among fetuses from aborted pregnancies (F. M% 
48,3:51,7) (9). Moreover, the incidence of fetal death is 
higher for males compared to females (10,11). Further-
more, female newborns have a better survival rate com-
pared to males (7,8).
Based on these data, it can be concluded that the out-
come of patients with Edwards syndrome is diffi cult to 
predict during pregnancy and neonatal period. The rea-
son lies in the fact that this population is so variable and 
the syndrome can be presented in various combinations 
of congenital defects. The clinical presentation may 
vary from easier to more severe forms. Our case is inter-
esting because of the length of our patient’s survival, 
although severe congenital malformations were found 
there, including congenital heart defects that are never 
operated due to their poor prognosis in Edwards syn-
drome. This case report systematically presents all med-
ical diagnostics and procedures used in the treatment, so 
we could understand their impact on the length of sur-
vival in our and other patients with Edwards syndrome. 
So far the approach to the treatment of liveborn infants 
with Edwards syndrome has caused a lot of confl icting 
opinions in medical society, mostly because of poor 
prognosis and the lack of data relating to the effi cacy of 
treatment. Does the application of intensive therapy 
have an effect on the length of survival?
A previous research from Japan suggests that it has. 
The authors reviewed detailed clinical data of 24 pa-
tients with complete trisomy 18, who were admitted to 
the Neonatal Intensive Care Unit of Nagano Children’s 
Figure 3. Cytogenetic fi ndings (GTG – banding method): female karyotype, full trisomy 18 (47, XX, + 18)
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Hospital, undergoing intensive treatment in the period 
from 1994 to 2003. Cesarean section, resuscitation by 
intubation, and surgical operations were performed on 
16 (67%), 15 (63%), and 10 (42%) of the patients, re-
spectively. Mechanical ventilation was required by 21 
patients (88%), and 6 (29%) of them were extubated. 
Survival rate at the age of 1 week, 1 month, and 1 year 
was 88%, 83%, and 25%, respectively. Survival beyond 
2 years (4%) was similar to the 5–10% usually reported 
as 1-year survival rate. Median survival time was 152,5 
days.
In this study the authors also investigated pathophys-
iologically the reasons of death in patients who had 
 intensive treatment, distinguishing the key factors 
 associated with death and fi nal mechanisms of death. 
The common key factors associated with death were 
congenital heart defects and heart failure, and pulmo-
nary hypertension. On the other hand, the fi nal modes of 
death were sudden cardiac or cardiopulmonary arrest 
and events related to progressive pulmonary hyperten-
sion. From these observations, it becomes clear that 
 apnea and withdrawal of treatment could be considered 
the major cause of death when a patient with trisomy 
18 was managed with purely comfort care. When a pa-
tient with trisomy 18 has intensive treatment, the com-
mon causes of death are altered, and survival does in-
crease (12).
Reviewing data from literature, and comparing it to 
the usage of intensive therapy, the length of survival 
and mechanism of death in our case, we can assume that 
the equal correlation between these parameters was 
confi rmed. An early application of intensive therapy in 
this group of patients has a signifi cant impact on the 
extension of life expectancy and outcomes in neonatal 
and infant period. However, the equalization of mortal-
ity rates after the second year of life raises the question 
if the application of intensive therapy is justifi ed, from 
the perspective of families of newborns who undergo 
aggressive medical procedures, and the quality of life 
that period of intensive and post-intensive care carries, 
but also from the perspective of the health care system 
that is additionally burdened by heavy fi nancial expens-
es in such cases. The intention of this paper is to provide 
access to all available information on intensive treat-
ment of patients with Edwards syndrome and to show 
what such treatment carries. These data should be used 
to help doctors in providing information to patients’ 
families and in cooperation with them in decision about 
treatment options for each individual case.
Conclusion
The application of intensive care in newborns with 
Edwards syndrome has effect on survival in neonatal 
and infant period. It has no effect on survival rate of 
patients in the period after the second year of life but 
may have effect on pathophysiological modus of death.
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Prikaz slučaja
Ključne riječi: Edwardsov sindrom, intezivno liječenje, preživljenje
SAŽETAK. Uvod. Edwardsov sindrom je druga najčešća autosomna kromosomska anomalija u čovjeka, s prevalencijom 
od 1:6000 – 1:8000 kod živorođene djece. Sindrom obuhvaća prepoznatljiv uzorak većih i manjih anomalija, te značajana 
psihomotorna i kognitivna oštečenja. Nosi povećani rizik od neonatalne i dojenačke smrtnosti. Više od 50 % djece  umire 
u prvom tjednu života, a manje od 10 % ih doživi prvu godinu života. Pristup u liječenju ovakvih pacijenata dosad je u 
pedijatrijskoj zajednici izazivao dosta kontroverza, jer dok jedni smatraju kako primjena intezivne terapije produžuje 
preživljenje, drugi smatraju kako nema dugoročni učinak i s obzirom na teška psihomotorna i kognitivna oštečenja da 
njezina primjena nije opravdana. Prikaz slučaja. Žensko novorođenče, rođeno 11.1.2014. premješteno je na JIL Klinike 
za pedijatriju SKB Mostar neposredno nakon poroda zbog hipotonije, sivoblijede boje kože, oskudne spontane motorike, 
respiratorno dekompenzirano. Klinički novorođenče je pokazivalo fenotipske karakteristike tipične za Edwardsov 
 sindrom. Odmah po prijemu pacijentica se intubira i stavi na strojnu ventilaciju. Isti dan se dijagnosticira dijafragmalna 
hernija i napravi se operativni zahvat. Citogenetskim nalazom se potvrdi potpuna trisomija 18. Ehografi jom srca nađu se 
VSD inlet tip (vel. 8 mm), ASD II (5 mm), PDA (3 mm). Daljom dijagnostičkom obradom nađu se i druge prirođene 
malformacije manje kliničke važnosti. Nakon stabilizacije postintezivno pacijentica nastavlja s kardiološkom terapijom 
i fi zijatrijskim tretmanom. Nakon otpusta više puta hospitalizirana, među ostalim zbog razvoja plućne hipertenzije i 
njenih komplikacija. Dijete je umrlo u lipnju 2016. od posljedica srčanog zatajenja, u dobi od dvije godine i šest mje seci. 
Zaključak. Primjena intezivnog liječenja kod naše pacijentice imala je utjecaj na njeno preživljenje. Također, pokazalo 
se kako kod ove bolesti primjena intezivnog liječenja nosi kardiovaskularna zbivanja kao glavni mehanizam umiranja, 
za razliku od neinvazivnog pristupa gdje se visok postotak umrlih povezuje s centralnom apnejom.
